-

Kaskela Law LLC MERGER INVESTIGATION: Does $9.55 Per Share Represent Sufficient Cash Out Value for Carrols Restaurant Group, Inc. (NASDAQ: TAST) Shares for Investors?

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC announces that it is investigating Carrols Restaurant Group, Inc. (NASDAQ: TAST) (“Carrols”) on behalf of the company’s shareholders.

On January 16, 2024, Carrols announced that it had agreed to be acquired by Restaurant Brands International Inc. at a price of $9.55 per share in cash. Following the closing of the proposed transaction, Carrols’ shareholders will be cashed out of their investment position and the company’s shares will no longer be publicly traded.

The investigation seeks to determine whether investors will be receiving sufficient consideration for their shares, and whether Carrols’ officers and/or directors breached their fiduciary duties or violated the securities laws in agreeing to sell the company at $9.55 per share. Notably, immediately prior to the announcement of the proposed transaction, at least one stock analyst was maintaining a price target for Carrols’ shares at $13.00 per share.

Carrols shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229–0750, or by email (skaskela@kaskelalaw.com / abell@kaskelalaw.com) or online at https://kaskelalaw.com/cases/carrols-restaurant-group/ , for additional information about this investigation and their legal rights and options with respect to this transaction.

Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation on a contingent basis. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com.

This notice may constitute attorney advertising in certain jurisdictions.

Contacts

D. Seamus Kaskela, Esq.
Adrienne Bell, Esq.
(888) 715–1740
(484) 229–0750
www.kaskelalaw.com

Industry:

Kaskela Law LLC

NASDAQ:TAST
Release Versions
English

Contacts

D. Seamus Kaskela, Esq.
Adrienne Bell, Esq.
(888) 715–1740
(484) 229–0750
www.kaskelalaw.com

More News From Kaskela Law LLC

Kaskela Law LLC Announces Investigation into Fairness of $9.50 Per Share Global Business Travel Group (GBTG) Stockholder Buyout; Affected Investors are Encouraged to Contact the Firm to Protect Their Investment and Legal Rights

NEWTOWN SQUARE, Pa.--(BUSINESS WIRE)--Kaskela Law is investigating the fairness of the recently announced buyout of Global Business Travel Group, Inc. (NYSE: GBTG) (“GBTG”) shareholders to determine whether the transaction as structured provides investors with a sufficient price for their GBTG shares. Click here to register for additional information about this investigation: https://kaskelalaw.com/case/global-business-travel-group/ On May 4, 2026, GBTG announced that it had agreed to go privat...

Kaskela Law LLC Announces Shareholder Investigation of Playtika Holding Corp. and Encourages Investors with Losses to Contact the Firm – PLTK

NEWTOWN SQUARE, Pa.--(BUSINESS WIRE)--Shareholder litigation law firm Kaskela Law is investigating Playtika Holding Corp. (NASDAQ: PLTK) (“Playtika”) on behalf of the company’s investors. Click here to register for additional information about this investigation: https://kaskelalaw.com/case/playtika-holding/ Since July 2025, shares of Playtika’s common stock have declined in value from a trading price of over $4.50 per share to a current price of less than $3.50 per share, a decline of over 22%...

Kaskela Law LLC Announces Investigation into Fairness of $16.50 Per Share Select Medical Holdings (SEM) Stockholder Buyout; Affected Investors are Encouraged to Contact the Firm to Protect Their Investment and Legal Rights

NEWTOWN SQUARE, Pa.--(BUSINESS WIRE)--Shareholder litigation law firm Kaskela Law is investigating the fairness of the recently announced buyout of Select Medical Holdings Corp. (NYSE: SEM) (“Select Medical”) shareholders to determine whether the transaction as structured provides investors with a sufficient price for their shares. Click here to register for additional information about this investigation: https://kaskelalaw.com/case/select-medical/ On March 2, 2026, Select Medical announced th...
Back to Newsroom